AMAROQ THERAPEUTICS

amaroq-therapeutics-logo

Amaroq Therapeutics is a biotechnology company that focuses on the development of next-generation cancer therapies. The company's research is centered around long non-coding RNAs, often referred to as the 'dark matter' of the human genome. These molecules, which were only recently discovered, are being explored for their potential in cancer treatment. Amaroq Therapeutics is developing novel cancer therapies that specifically target these long non-coding RNAs. The company's work is based on research spun out of the University of Otago in Dunedin, New Zealand.

#Website #More

AMAROQ THERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science Therapeutics

Founded:
2021-01-01

Address:
Auckland, Auckland, New Zealand

Country:
New Zealand

Website Url:
http://www.amaroqtx.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Euro U.S. Server Location


Official Site Inspections

http://www.amaroqtx.com

  • Host name: 151.101.194.159
  • IP address: 151.101.194.159
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Amaroq Therapeutics"

amaroq | Nothing Remains Concealed

Targeting long non-coding RNAs for next generation cancer therapiesSee details»

About | amaroq - amaroqtx.com

Long non-coding RNAs are a relatively recently discovered class of molecules often referred to as โ€œdark matterโ€ of the human genome. These naturally occurring molecules do not code for proteins but fulfill important regulatory functions in โ€ฆSee details»

Amaroq Therapeutics - Crunchbase Company Profile

Contact Email [email protected] Amaroq Therapeutics is a biotechnology company that focuses on the development of next-generation cancer therapies. The company's research is centered around long non-coding RNAs, often โ€ฆSee details»

Amaroq Therapeutics Company Profile | Management and

Www.amaroqtx.com . Amaroq Therapeutics Profile and History. Amaroq Therapeutics is a New Zealand-based biotechnology company focused on developing a new class of therapeutics โ€ฆSee details»

Amaroq Therapeutics - LinkedIn

Amaroq Therapeutics is a New Zealand-based biotechnology company focused on developing a new class of therapeutics that target lncRNA in cancer. Long non-coding RNAs are a relatively โ€ฆSee details»

Amaroq Therapeutics - Company Profile & Staff Directory

Amaroq Therapeutics is a New Zealand-based biotechnology company focused on developing a new class of therapeutics that target lncRNA in cancer. Long non-coding RNAs are a relatively โ€ฆSee details»

Amaroq Therapeutics Company Profile 2024: Valuation, โ€ฆ

Amaroq Therapeutics General Information Description. Operator of a biotech company intended to develop cancer treatment drugs. The company's RNA therapy leverages IncRA molecules as a therapeutic target and diagnostic โ€ฆSee details»

Amaroq Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...

Explore Amaroq Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 2 news.See details»

Amaroq - Overview, News & Similar companies | ZoomInfo.com

View Amaroq (amaroq.design) location in Texas, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

Amaroq Therapeutics - Company Profile - Tracxn

Dec 1, 2024 Email ID: *****@amaroqtx.com; Key Metrics. Total Funding. $9.83M in 1 round. Latest Funding Round. Series A, Jul 08, 2021, $9.83M. Investors. Brandon Capital & 4 more. โ€ฆSee details»

Amaroq Therapeutics - Overview, News & Similar companies

Www.amaroqtx.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. Leading New Zealand cancer research 'super-charged' by data ...See details»

Amaroq Therapeutics - Products, Competitors, Financials, โ€ฆ

Amaroqtx.com. Overview & Products; Financials; People; Founded Year 2021. Stage Seed VC | Alive. Total Raised $9.7M. Last Raised $9.7M | 3 yrs ago. About Amaroq Therapeutics. โ€ฆSee details»

Contact | amaroq - amaroqtx.com

For any further information about Amaroq Therapeutics, please contact us by submitting the form below.See details»

Amaroq Therapeutics - VentureRadar

Website: https://amaroqtx.com/ Develops innovative therapeutics targeting lncRNA in cancer, focusing on tumor-specific drivers and high unmet clinical needs, such as ...See details»

Company Information - RocketReach

Amaroqtx.com; otago.ac.nz; View Similar People. Related Companies Curative NZ. 20 $8.8m NinjaKiwi. 81 $6.7m Easy Crypto. 49 HIND Management. 41 $2m First AML. 108 $25.2m โ€ฆSee details»

Amaroq Therapeutics - VentureRadar

"Amaroq Therapeutics is a biotechnology company focussed on developing a new class of therapeutics that target lncRNA in cancer. LncRNAs regulate gene expression through many โ€ฆSee details»

Technology | amaroq - amaroqtx.com

Most research into cancer drugs has focused on modulating protein function. However, only 1-2% of the human genome encodes for proteins, and the majority of cancer-associated mutations โ€ฆSee details»

AURORA Target ID Pipeline | amaroq - amaroqtx.com

Amaroq Theraputics © 2021. error: Content is protected !!See details»

News & Publications | amaroq - amaroqtx.com

Jul 7, 2021 Pinkney HR, Black MA, Diermeier SD.Single-cell RNA-seq reveals heterogenous lncRNA expression in xenografted triple-negative breast cancer cells. Biology 2021 Sep 30;10 โ€ฆSee details»